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A Prion in yeast 
Huntington’s disease
Huntingtin-like proteins 
make yeast sick (bottom).
 
eriin et al., reporting on page 997, have developed
the first yeast model for studying Huntington’s disease. 
Yeast cannot undergo neurodegeneration, of course, but the 
simplicity and genetic manipulability of the system are already 
providing important mechanistic insights. The authors report 
that aggregation of a polypeptide with an expanded poly-
glutamine domain, mediated by a prion-like protein, is 
responsible for cell death in their system, suggesting revisions 
to earlier models of neurodegeneration.
In Huntington’s disease, expansion of the huntingtin 
polyglutamine domain leads to protein aggregation in inclusion 
bodies and neuronal cell death. In some systems, however, 
long polyglutamine peptides are toxic without aggregating, 
suggesting that aggregation of mutant huntingtin might not 
determine toxicity. Meriin and colleagues found, however, 
that aggregation of long polyglutamine peptides in yeast 
correlated with toxicity. Mutations in certain chaperone 
M
 
genes, or curing the cells of the prion form of the Rnq1 protein, suppressed both 
aggregation and toxicity.
The results directly link polyglutamine peptide aggregation with cell death, and 
demonstrate that prion proteins are required for this process, at least in yeast. The evolutionary 
conservation of these mechanisms suggests that prion-like proteins might also be involved 
in mammalian polyglutamine expansion diseases.
 
 
 
 
 
How ﬁsh 
oils work
 
or years, epidemiologists 
and nutritionists have known 
that a diet high in the v-3 fatty 
acids found in fish oil correlates 
with a decreased risk of colon 
cancer. On page 915, 
Murray et al. explain why.
As colon carcinogenesis is 
accompanied by an increase 
in the expression of the lipid-
dependent protein kinase C
 
 
 
II 
(PKC
 
 
 
II), the authors reasoned 
that 
 
 
 
-3 fatty acids might inhibit 
PKC
 
 
 
II signaling. Analysis of rat 
colonic epithelia and PKC
 
 
 
II 
transgenic mice demonstrated 
that 
 
 
 
-3 fatty acids block 
F
 -3 (right), but not  -6 (left), 
fatty acids restore TGF RII 
expression.
 
PKC
 
 
 
II activation and reduce 
the pro-carcinogenic effects 
of PKC
 
 
 
II in vitro and in vivo. 
PKC
 
 
 
II appears to repress the 
expression of transforming 
growth factor 
 
 
 
 receptor II 
(TGF
 
 
 
RII), desensitizing cells 
to the growth-inhibiting effects 
of TGF
 
 
 
.
The results suggest that 
 
 
 
-3 
fatty acids inhibit PKC
 
 
 
II, thus 
relieving the inhibition of 
TGF
 
 
 
RII expression. This renders 
colon epithelial cells sensitive to 
TGF
 
 
 
, and prevents or reverses 
the hyperproliferative state that 
leads to colon cancer. Dietary 
 
 
 
-3 fatty acids are also associ-
ated with preventing prostate 
and breast cancer and some 
neurological conditions, 
suggesting that PKC
 
 
 
II may be 
a promising target for multiple 
chemoprevention strategies.
 
 
 
 
 
A vitamin makes minerals
 
rowth plate chondrocytes help turn cartilage into bone by releasing specialized matrix 
vesicles, which contain the crystaline seeds for calcification. On page 1061, Wang and
Kirsch show how retinoic acid (vitamin A) controls this process of mineralization.
Previous work showed that retinoic acid stimulates mineralization and induces the 
formation of matrix vesicles, but its molecular targets remained unknown. In the new 
study, the authors found that, in cultured growth plate chondrocytes, retinoic acid acts 
by increasing the transcription of three annexin family proteins and causing them to 
form calcium channels in the plasma membrane.
Retinoic acid is known to regulate transcription 
after binding to the retinoic acid receptor complex, 
but the new results imply that it can also control 
calcium homeostasis, perhaps through receptors yet 
to be discovered. After retinoic acid induces an 
initial calcium influx, the formation of induced 
annexins into channels in the plasma membrane 
further boosts cytosolic calcium, increasing annexin 
expression again and causing the release of matrix 
vesicles. These vesicles contain annexin channels 
that allow the entry of crystal-forming calcium.
Excess mineralization has been implicated in 
several disease processes, including osteoarthritis 
and the calcification of cardiovascular tissues. 
Recently, the authors have determined that annexin 
expression is induced in osteoarthritic chondrocytes. If annexins are as central to pathogenic 
mineralization as they appear to be in healthy tissue, they could be promising targets for a 
variety of therapies. 
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Vitamin A induces bone mineralization.
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